Scientists launch 20-Year quest to unlock secrets of rare blood disorder
NCT ID NCT05350748
Summary
This study aims to learn more about myelodysplastic syndromes (MDS), a group of rare blood disorders, by observing how the disease naturally progresses over a very long time. Researchers will enroll about 1,100 people, including those with MDS and healthy donors, to collect blood, bone marrow, and other samples. The goal is to gather detailed information to help scientists develop better future treatments, not to test a new therapy on participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.